Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public Health Intervention Study

Platform performance will be combined measure based on the coverage and feasibility measured by the following parameters and implementation outcome indicators:

• Platform reach: Program reach and therapeutic coverage
• Platform feasibility: Extent of changes to established procedures and requirements in terms of resources for social mobilization, training, drug logistics and drug delivery Feasibility will be assessed through quantitative and qualitative data on operational aspects
• Platform acceptability/suitability: quantitative and qualitative feedback by stakeholders (health system & population perspective) assessed through Questionnaires & FGDs with parents and community stakeholders, KIIs and transect walks with health workers and programmatic supervision/monitoring tools and review meetings of implementers

For the analysis and selection of a platform, a prioritization matrix will be developed which enables a triangulation and weighing of the above mentioned indicators.

The effectiveness of the advocacy, social mobilization and communication campaign will be measured as a combined measure by the following indicators:

• Appropriateness of the tools (content, distribution channel, locations, timetable)
• Acceptability of messages and motivation to access treatment
• Coverage and scope of social mobilization
• Feasibility in terms of equipment, personnel and timetable using questionnaires, FGDs, KIIs, non-participative observations through social scientists and routine monitoring and supervision tools as well as training knowledge assessment forms applied by the platforms and monitoring and evaluation teams.

For the analysis and selection of a platform with regard to its social mobilization and communication effectiveness, a prioritization matrix will be developed which enables a triangulation and weighing of the above mentioned indicators.